Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02722083 · ClinicalTrials.gov registry record · Phase 2
Exploratory Study for Allergy Relief Onset
A Phase 2 study, sponsored by Bayer.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT02722083 is a Phase 2 study that was terminated before completion, run by Bayer. The registered enrollment target is 1 participants.
The verdict
NCT02722083, a Phase 2 study, was terminated before completion, sponsored by Bayer.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of the study is to explore the onset of effect of an antihistamine in a controlled environment.
Interventions
- DRUG Placebo
- DRUG Chlorpheniramine maleate (BAY X002134)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-05-07 |
| Est. Completion | 2016-07-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02722083
The ClinicalTrials.gov registry entry for NCT02722083 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02722083 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02722083 about?
NCT02722083 is a clinical study titled "Exploratory Study for Allergy Relief Onset". The purpose of the study is to explore the onset of effect of an antihistamine in a controlled environment.
What is the current status of trial NCT02722083?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2016-05-07. Estimated completion is 2016-07-13.
What interventions are being tested in trial NCT02722083?
The interventions under investigation include: Placebo (DRUG), Chlorpheniramine maleate (BAY X002134) (DRUG).
Who is sponsoring clinical trial NCT02722083?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.